16.98
0.24%
+0.04
Core Laboratories Inc stock is currently priced at $16.98, with a 24-hour trading volume of 3,171.
It has seen a +0.24% increased in the last 24 hours and a -0.59% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $17.09 pivot point. If it approaches the $16.63 support level, significant changes may occur.
Previous Close:
$16.94
Open:
$16.92
24h Volume:
3,171
Market Cap:
$790.50M
Revenue:
$502.79M
Net Income/Loss:
$23.71M
P/E Ratio:
33.96
EPS:
0.5
Net Cash Flow:
$6.35M
1W Performance:
+0.06%
1M Performance:
-0.59%
6M Performance:
-22.39%
1Y Performance:
-24.57%
Core Laboratories Inc Stock (CLB) Company Profile
Name
Core Laboratories Inc
Sector
Industry
Phone
31 20 420 3191
Address
Strawinskylaan 913, Tower A Level 9, Amsterdam
Core Laboratories Inc Stock (CLB) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jun-30-23 | Downgrade | Citigroup | Neutral → Sell |
Apr-18-23 | Downgrade | BofA Securities | Neutral → Underperform |
Jan-09-23 | Upgrade | BofA Securities | Underperform → Neutral |
Oct-07-22 | Upgrade | Citigroup | Sell → Neutral |
Sep-26-22 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
Apr-18-22 | Downgrade | Piper Sandler | Neutral → Underweight |
Oct-18-21 | Downgrade | BofA Securities | Neutral → Underperform |
Jul-09-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Jun-14-21 | Downgrade | Citigroup | Neutral → Sell |
Dec-18-20 | Downgrade | JP Morgan | Neutral → Underweight |
Nov-11-20 | Reiterated | Cowen | Market Perform |
Oct-13-20 | Upgrade | BofA Securities | Underperform → Neutral |
Sep-29-20 | Upgrade | ABN Amro | Sell → Hold |
Jul-16-20 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
Apr-13-20 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
Mar-09-20 | Downgrade | BofA/Merrill | Buy → Underperform |
Mar-09-20 | Downgrade | Evercore ISI | Outperform → In-line |
Jan-31-20 | Reiterated | Cowen | Market Perform |
Jan-30-20 | Resumed | Johnson Rice | Buy |
Jan-14-20 | Initiated | Bernstein | Mkt Perform |
Jan-02-20 | Downgrade | Stifel | Buy → Hold |
Dec-31-19 | Reiterated | Cowen | Market Perform |
Jul-10-19 | Upgrade | BofA/Merrill | Neutral → Buy |
Feb-25-19 | Upgrade | Tudor Pickering | Hold → Buy |
Dec-19-18 | Downgrade | Credit Suisse | Outperform → Neutral |
Dec-11-18 | Downgrade | JP Morgan | Overweight → Neutral |
Nov-16-18 | Upgrade | Guggenheim | Neutral → Buy |
Nov-01-18 | Upgrade | ABN Amro | Sell → Buy |
Oct-29-18 | Reiterated | Cowen | Market Perform |
View All
Core Laboratories Inc Stock (CLB) Latest News
Core Laboratories (CLB) Q1 Earnings and Sales Beat Estimates
Zacks Investment Research
Kinder Morgan (KMI) Beats on Q1 Earnings, Hikes Dividend
Zacks Investment Research
Sunoco (SUN) Proceeds With Strategic Portfolio Optimization
Zacks Investment Research
What Makes Core Laboratories (CLB) a New Strong Buy Stock
Zacks Investment Research
Christina Lake Cannabis Provides Bi-Weekly Update on Status of MCTO
GlobeNewswire Inc.
Earnings Preview: Core Laboratories (CLB) Q1 Earnings Expected to Decline
Zacks Investment Research
Core Laboratories Inc Stock (CLB) Financials Data
Core Laboratories Inc (CLB) Revenue 2024
CLB reported a revenue (TTM) of $502.79 million for the quarter ending March 31, 2023, a +5.37% rise year-over-year.
Core Laboratories Inc (CLB) Net Income 2024
CLB net income (TTM) was $23.71 million for the quarter ending March 31, 2023, a +143.62% increase year-over-year.
Core Laboratories Inc (CLB) Cash Flow 2024
CLB recorded a free cash flow (TTM) of $6.35 million for the quarter ending March 31, 2023, a -69.10% decrease year-over-year.
Core Laboratories Inc (CLB) Earnings per Share 2024
CLB earnings per share (TTM) was $0.50 for the quarter ending March 31, 2023, a +140.38% growth year-over-year.
About Core Laboratories Inc
Core Laboratories N.V. provides reservoir description, and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates in two segments, Reservoir Description and Production Enhancement segments. The Reservoir Description segment comprises the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. This segment offers laboratory-based analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry. It also provides proprietary and joint industry studies. The Production Enhancement segment includes services and products relating to reservoir well completions, perforations, stimulations, and production. This segment offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories N.V. was founded in 1936 and is based in Amsterdam, the Netherlands.
Cap:
|
Volume (24h):